First Time Loading...

XOMA Corp
NASDAQ:XOMA

Watchlist Manager
XOMA Corp Logo
XOMA Corp
NASDAQ:XOMA
Watchlist
Price: 25.44 USD -1.47% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

XOMA Price Targets Summary
XOMA Corp

Wall Street analysts forecast XOMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XOMA is 58.14 USD with a low forecast of 40.4 USD and a high forecast of 77.7 USD.

XOMA Lowest Forecast
Wall Street Target
40.4 USD
59% Upside
XOMA Average Forecast
Wall Street Target
58.14 USD
129% Upside
XOMA Highest Forecast
Wall Street Target
77.7 USD
205% Upside
Lowest
Price Target
40.4 USD
59% Upside
Average
Price Target
58.14 USD
129% Upside
Highest
Price Target
77.7 USD
205% Upside
XOMA Corp Competitors:
Price Targets
603387
Getein Biotech Inc
298% Upside
HPHA
Heidelberg Pharma AG
287% Upside
S
002880
Shenzhen Weiguang Biological Products Co Ltd
43% Upside
ZEAL
Zealand Pharma A/S
31% Upside
603387
Getein Biotech Inc
298% Upside
HPHA
Heidelberg Pharma AG
287% Upside
S
002880
Shenzhen Weiguang Biological Products Co Ltd
43% Upside
ZEAL
Zealand Pharma A/S
31% Upside
DSGN
Design Therapeutics Inc
30% Upside
068270
Celltrion Inc
30% Upside
MRNA
Moderna Inc
7% Upside
GRTS
Gritstone bio Inc
494% Upside

Revenue
Forecast

Revenue Estimate
XOMA Corp

For the last 8 years the compound annual growth rate for XOMA Corp's revenue is -26%. The projected CAGR for the next 3 years is 87%.

-26%
Past Growth
87%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
XOMA Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
XOMA Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
What are analyst estimates?

See Also

Summary
XOMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
XOMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XOMA stock valuation using valuation multiples.
Wall Street Estimates
XOMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XOMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XOMA's stock price target?
Price Target
58.14 USD

According to Wall Street analysts, the average 1-year price target for XOMA is 58.14 USD with a low forecast of 40.4 USD and a high forecast of 77.7 USD.

What is XOMA Corp's Revenue forecast?
Projected CAGR
87%

For the last 8 years the compound annual growth rate for XOMA Corp's revenue is -26%. The projected CAGR for the next 3 years is 87%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.